January 25, 2021
Expert details the potential for a clinical trial using minimal residual disease to guide therapy for patients with DLBCL.
January 23, 2021
Merryman explains the value of evaluating separate transplant-related questions for patients with relapsed or refractory diffuse large B-cell lymphoma.
January 21, 2021
Thought leader detailed the findings from an oral presentation investigating patients with relapsed or refractory diffuse large B-cell lymphoma.
January 13, 2021
Merryman provided background for the study design investigating patients with relapsed or refractory diffuse large B-cell lymphoma.